Hepatitis C Clinical Trial
Official title:
Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan
Following guidelines issued by the Centers for Disease Control, the Clinical Center
implemented a Universal Precautions policy in November 1987 in an attempt to reduce
healthcare workers' risks for occupational exposures to bloodborne pathogens. All hospital
personnel whose jobs entailed potential exposure to patients' blood and body substances were
required to attend a training session and complete a written examination. Based on data from
surveys conducted before and twelve months after training in Universal Precautions, the
frequency of cutaneous exposure to blood decreased by 50% in temporal association with
implementation of Universal Precautions. Staff at the Clinical Center are required to take a
refresher course in Universal Precautions annually.
The prevalence of bloodborne infections is high in Japan; however, Universal Precautions are
not widely practiced in Japan. This study is designed: 1) to evaluate and compare nurses'
knowledge of the epidemiology, pathogenesis, occupational risks, and appropriate prevention
strategies for managing patients infected with bloodborne pathogens in the healthcare
setting in seven university hospitals in Japan and at the Clinical Center of the National
Institutes of Health in the US; 2) to compare self-reported levels of compliance with
existing infection control recommendations designed to limit risk for exposure to bloodborne
pathogens in all four institutions; 3) to compare self-reported frequencies of cutaneous
exposures to blood at the four hospitals in the study; and 4) to evaluate the effect of
educational intervention on nurses perceived compliance with recommendations and on the
frequency of self-reported exposures to blood.
Following guidelines issued by the Centers for Disease Control, the Clinical Center
implemented a Universal Precautions policy in November 1987 in an attempt to reduce
healthcare workers' risks for occupational exposures to bloodborne pathogens. All hospital
personnel whose jobs entailed potential exposure to patients' blood and body substances were
required to attend a training session and complete a written examination. Based on data from
surveys conducted before and twelve months after training in Universal Precautions, the
frequency of cutaneous exposure to blood decreased by 50% in temporal association with
implementation of Universal Precautions. Staff at the Clinical Center are required to take a
refresher course in Universal Precautions annually.
The prevalence of bloodborne infections is high in Japan; however, Universal Precautions are
not widely practiced in Japan. This study is designed: 1) to evaluate and compare nurses'
knowledge of the epidemiology, pathogenesis, occupational risks, and appropriate prevention
strategies for managing patients infected with bloodborne pathogens in the healthcare
setting in seven university hospitals in Japan and at the Clinical Center of the National
Institutes of Health in the US; 2) to compare self-reported levels of compliance with
existing infection control recommendations designed to limit risk for exposure to bloodborne
pathogens in all four institutions; 3) to compare self-reported frequencies of cutaneous
exposures to blood at the four hospitals in the study; and 4) to evaluate the effect of
educational intervention on nurses perceived compliance with recommendations and on the
frequency of self-reported exposures to blood.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Recruiting |
NCT04510246 -
Link Hepatitis C Notifications to Treatment in Tasmania
|
N/A | |
| Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
| Completed |
NCT03109457 -
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
|
||
| Completed |
NCT03118674 -
Harvoni Treatment Porphyria Cutanea Tarda
|
Phase 2 | |
| Completed |
NCT01458054 -
Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults
|
Phase 1 | |
| Completed |
NCT03740230 -
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
|
||
| Completed |
NCT03426787 -
Helping Empower Liver and Kidney Patients
|
N/A | |
| Completed |
NCT03627299 -
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
|
Phase 4 | |
| Completed |
NCT00006301 -
Immune Response to Hepatitis C Virus
|
||
| Active, not recruiting |
NCT03949764 -
The Kentucky Viral Hepatitis Treatment Study
|
Phase 4 | |
| Completed |
NCT03365635 -
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
|
Phase 4 | |
| Recruiting |
NCT04405024 -
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients
|
N/A | |
| Completed |
NCT04525690 -
Improving Inpatient Screening for Hepatitis C
|
N/A | |
| Completed |
NCT04033887 -
Evaluation Study of RDTs Detecting Antibodies Against HCV
|
||
| Withdrawn |
NCT04546802 -
HepATocellular Cancer Hcv Therapy Study
|
Phase 3 | |
| Active, not recruiting |
NCT02961426 -
Strategic Transformation of the Market of HCV Treatments
|
Phase 2/Phase 3 | |
| Completed |
NCT02705534 -
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
|
Phase 3 | |
| Completed |
NCT03186313 -
A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection
|
Phase 3 | |
| Completed |
NCT02992184 -
PoC-HCV Genedrive Viral Detection Assay Validation Study
|
N/A |